2009
DOI: 10.1016/j.regpep.2008.09.007
|View full text |Cite
|
Sign up to set email alerts
|

Human adrenomedullin combined with human adrenomedullin binding protein-1 is protective in gut ischemia and reperfusion injury in the rat

Abstract: Previous studies have demonstrated that co-administration of rat adrenomedullin (AM) and human AM binding protein-1 (AMBP-1) has various beneficial effects following adverse circulatory conditions. In order to reduce rat proteins to elicit possible immune responses in humans, we determined the effect of human AM combined with human AMBP-1 after intestinal ischemia and reperfusion (I/R). Intestinal ischemia was induced in the rat by occluding the superior mesenteric artery for 90 min. At 60 min after the beginn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
10
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(13 citation statements)
references
References 48 publications
3
10
0
Order By: Relevance
“…This is in accordance with previous studies that demonstrated the beneficial action of AM after ischemia-reperfusion injury in other organs [52,59,84,105]. Administration of AM/AMBP-1 downregulates gene expression and protein levels of proinflammatory cytokines, such as TNF-a and IL-6, in the small intestine, preserves gut barrier function, reduces remote organ injury improving perfusion both locally and systemically, and improves survival rate [190,191].…”
Section: Adrenomedullin Protects Against Intestinal Ischemiasupporting
confidence: 91%
See 1 more Smart Citation
“…This is in accordance with previous studies that demonstrated the beneficial action of AM after ischemia-reperfusion injury in other organs [52,59,84,105]. Administration of AM/AMBP-1 downregulates gene expression and protein levels of proinflammatory cytokines, such as TNF-a and IL-6, in the small intestine, preserves gut barrier function, reduces remote organ injury improving perfusion both locally and systemically, and improves survival rate [190,191].…”
Section: Adrenomedullin Protects Against Intestinal Ischemiasupporting
confidence: 91%
“…There is emerging evidence that co-administration of AM and AMBP-1 should be considered as a novel approach to prevent injury after gut ischemia [190]. This is in accordance with previous studies that demonstrated the beneficial action of AM after ischemia-reperfusion injury in other organs [52,59,84,105].…”
Section: Adrenomedullin Protects Against Intestinal Ischemiasupporting
confidence: 88%
“…Our survival study showed that human AM/AMBP-1 treatment significantly improved the survival from 41% to 81%, which was mostly seen on day 1. Organ injury markers have been used as measures to determine the degree of damage caused by models of organ injury such as sepsis, hemorrhagic shock, and ischemia/reperfusion injury 17,21,22,25 . These markers provide a way to compare the severity of damage to that is seen in clinical scenarios.…”
Section: Discussionmentioning
confidence: 99%
“…The THI rats with vehicle treatment received low dose of human albumin for a period of 30 min. The dosage of AM/AMBP-1 was similar to that was used recently in a rat model of gut ischemia and reperfusion injury 21 .…”
Section: Methodsmentioning
confidence: 99%
“…These initial studies were conducted with rat AM and human AMBP-1. Recently, we have also reported that combined treatment of human AM and human AMBP-1 reduced organ injury and inflammatory responses, and improved survival in rat models of hemorrhagic shock and gut ischemia/reperfusion injury (30, 31). In the current study, we examined whether administration of human AM combined with human AMBP-1 can minimize or prevent the damage induced by acute renal I/R injury in rats.…”
Section: Introductionmentioning
confidence: 97%